Topiramate in managing impulse control disorders in Parkinson's disease.
Bermejo
Pedro Emilio
PE
D000927:Anticonvulsants / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000009:adverse effects; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D012720:Severity of Illness Index; D000077236:Topiramate
D000927:Anticonvulsants; D000978:Antiparkinson Agents; D000077236:Topiramate; D005632:Fructose